National Wealth Management Group LLC Takes $436,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

National Wealth Management Group LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 836 shares of the medical equipment provider’s stock, valued at approximately $436,000.

Several other large investors have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Summit Securities Group LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $30,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $31,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $495.27 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market cap of $176.40 billion, a price-to-earnings ratio of 77.27, a PEG ratio of 5.85 and a beta of 1.43. The business’s 50 day moving average price is $554.33 and its 200-day moving average price is $532.98.

Analyst Ratings Changes

ISRG has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Jefferies Financial Group increased their price objective on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Truist Financial reduced their target price on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. Finally, Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.